Microbot MedicalFRA:CY9D +0.30%30 Quick Ratio is 21.93 as of Mar. 2026, which is 184% above its 10-year median of 7.71. GuruFocus rates FRA:CY9D with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Microbot Medical ranks better than 98.83% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Microbot Medical's quick ratio for the quarter that ended in Mar. 2026 was 21.93.
Microbot Medical has a quick ratio of 21.93. It generally indicates good short-term financial strength.
The historical rank and industry rank for Microbot Medical's Quick Ratio or its related term are showing as below:
FRA:CY9D'
s Quick Ratio Range Over the Past 10 Years
Min: 0.46 Med: 7.71 Max: 33.8
Current: 21.93
During the past 13 years, Microbot Medical's highest Quick Ratio was 33.80. The lowest was 0.46. And the median was 7.71.
FRA:CY9D's Quick Ratio is ranked better than 98.83% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.885
vs FRA:CY9D: 21.93
Microbot Medical (FRA:CY9D) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Microbot Medical Quick Ratio Related Terms
Microbot Medical Quick Ratio Historical Data
* Premium members only.
The historical data trend for Microbot Medical's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:CY9D vs STXS, POCI, DXR: Quick Ratio Comparison
For the Medical Instruments & Supplies subindustry, Microbot Medical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbot Medical Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Microbot Medical's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Microbot Medical's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbot Medical (FRA:CY9D) has a Quick Ratio of 21.93 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Microbot Medical and its competitors. This is 184% above median its historical median of 7.71. Over the past decade, Microbot Medical's Quick Ratio has ranged from 0.46 to 33.80. According to the industry distribution chart, Microbot Medical ranks #10 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 1.2%.
Is Microbot Medical's Quick Ratio too high?
Microbot Medical's current Quick Ratio of 21.93 is 184% above median its 10-year median of 7.71. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 33.80. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Microbot Medical's value of 21.93 is 1063.4% above this industry median. Based on the distribution chart, Microbot Medical ranks #10 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Microbot Medical has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's Quick Ratio compare to STXS and POCI?
According to the Medical Devices & Instruments industry distribution chart, Microbot Medical ranks #10 out of 854 companies for Quick Ratio. This places Microbot Medical in the top 1% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.89. Microbot Medical's value of 21.93 is 1063.4% above this benchmark. Historically, Microbot Medical's own Quick Ratio has ranged from 0.46 to 33.80 over the past decade. While the company's 10-year median is 7.71 vs. the industry median of 1.89, Microbot Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Microbot Medical's current Quick Ratio of 21.93 is 1063.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Microbot Medical and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbot Medical's current Quick Ratio is 21.93, which is 184% above median its own 10-year median of 7.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (FRA:CY9D) has a current Quick Ratio of 21.93. The current Quick Ratio is 21.93, which is 184% above median its 10-year median of 7.71 and 1063.4% above the Medical Devices & Instruments industry median of 1.89. Microbot Medical's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Microbot Medical (FRA:CY9D), the current Quick Ratio is 21.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
30GF Score
Get the complete analysis for FRA:CY9D
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CY9D has been successfully added to your 
